Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |